Boston Scientific (BSX) logo

Boston Scientific (BSX) stock

Medical devices , market cap $62B

Close
$44.32
+5.57%

After-hours $44.19 -0.30%

As of 7:08 PM ET after-hours, delayed 15+ min · Live for Pro members

Quality Score
0
Below Average
In its industry
#68of 85

BSX's Quality Score fell 1 point on Mon, Nov 2, to 0.

See BSX's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is BSX down?

Up 5.6% today, while its medical device peers are down 0.3%; no story names it yet.

Fell on Oct 28

Down 6% on Oct 28, and still 7% under its Oct 27 close.

  • Its Oct 28 results: net income was $0.40, from $0.51 a year before; adjusted earnings per share were $0.73, from $0.75. It fell 6% on Oct 28.

Sources: Price history, Oct 28, 2026; Company release, Oct 28, 2026

1 more reason, free with an account →3 more reasons why BSX fell on Oct 28, from its filings, with the timeline and its peers, for Pro members.

Key facts on BSX

Key facts on BSX
Holding it backBelow its 200-day since January down 56% in a year
Latest filing8-K, Oct 28 Reported its quarterly results
1 more reason behind BSX's 0, free with an account →4 more reasons behind BSX's 0, for Pro members.

BSX in the news

TodayNo story names it yet.

What's next

Wed Nov 11: Stifel Healthcare Conference 2026Investor conference · date confirmed.

BSX catalysts

Coming up

After its last 4 reports it closed -3.6% on average, higher 1 of 4 times.

40 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why BSX scores 0

Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

Well below its recent run. BSX scores 0 today, against a median of 6 over its last 20 recorded sessions.

  • −3Long-term trend below a falling 200-⁠day average, down over one year, down over two years
  • −3News guidance cut, earnings beat
  • Chart checks adds
  • Size adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
  • Growth addsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
  • Government filings subtracts

No effect today: Run-up, Dilution, Volatility, Cash flow, Persistence, and Insider trades.

What every line is worth, and the reason behind it, on BSX and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 7:08 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when BSX's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on BSX and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

BSX has 2 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on BSX, and all 14 on every stock.Get in free →

BSX RSI today: 50.9, below its 50-day and 200-day averages

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

The deep dive on BSX

14 more findings on BSX, each with its source, for Pro membersGet in free →

How BSX ranks in Medical Devices

BSX is #68 of 85 by Quality Score.

How BSX ranks in Medical Devices
68Boston Scientific (BSX) logoBSXBoston Scientific0

Net income over four quarters: BSX $3.67B, MDT $5.23B, PEN $161M.

More in Medical Devices

When does BSX report earnings, and what happens after?

Expected to report Wed Feb 10, before the open (in 100 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What BSX reported on Oct 28, 2026

The quarter

Sales of $5.1B, 1% more than a year ago; a profit of $0.40 a share, from $0.51.

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

BSX's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Full year 2026
Net sales growth, reportedabout 4.25%cut

Figures as filed (SEC filing, Oct 28)

5 more outlook lines, for Pro members.

The numbers

Market value
$62B
today
Sales
$21B
up 13.5% on the year
Free cash flow
$3.6B
last 12 months

Sales grew 15% a year over 5 years, fiscal 2020 to 2025.

Its share count grew 1.1% a year over 5 years.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on BSX: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
ReportedGapReaction5
sessions
Oct 28, 2026Before open-6.9%-5.8%open
Jul 29, 2026Before open-7.4%-0.0%+6.6%
Apr 22, 2026Before open+5.0%+9.0%-1.8%

BSX closed higher after 1 of its last 4 reports.

All 4 reports, and BSX's Quality Score going into each

BSX sales and profit by year

Sales and profit by year

Sales grew in six of the last seven years, to $20B in 2025. It made a profit in seven of the eight years.

Insiders trading BSX

BSX insider trades

5 insiders bought $10M across 10 filings in the last 6 months. No open-⁠market sales on record. The newest:

BuySusan E. Morano$100KDirectorat $49.22 on Aug 25, filed Aug 26
All 10 insider filings on BSX from the last six months, for Pro members.Get in free →

All BSX insider trades

BSX trades by Congress and the executive branch

51 trades disclosed in the last six months. The newest:

BuyDonald Trump$15K to $50KPresident (R)traded Aug 28, disclosed Oct 8(41 days later)
All 51 trades on BSX disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

BSX's officers and directors

Officers and directors with a Form 4 in the last 12 months.

8 more officers and directors file at BSX. Each page above names the rest.

See insider trades by person

Which ETFs hold BSX?

In ETFs: BSX is under 0.1% of SPYI, under 0.1% of VOO, and under 0.1% of IVV, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.

About Boston Scientific

Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

59,000 employeesMarlborough, MAbostonscientific.com

What Boston Scientific says it competes with

“We encounter significant competition across our business segments, product lines and markets, from global and local competitors.”

From its annual report, SEC filing · Feb 17, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

BSX's score card

Boston Scientific (BSX): Quality Score 0, Below Average, #68 of 85 in Medical Devices, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would turn BSX's score around: 5 things
  • 4 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayOct 8Donald Trump bought BSX$15K to $50K, disclosed Oct 8

Alerts are optional.

See BSX's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: BSX's Quality Score is 0 (Below Average), #68 of 85 in Medical Devices. Insiders bought $10M in the last 6 months (Form 4).

Is BSX a good stock to buy? What its Quality Score says

BSX scores 0 today, which Breakaway calls Below Average. It is #68 of 85 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Down 6% on Oct 28, and still 7% under its Oct 27 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is BSX's Quality Score?

BSX scores 0 today, which Breakaway calls Below Average (0 to 5). That is #68 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind BSX's 0.

Are insiders buying BSX?

5 insiders bought $10M across 10 filings in the last 6 months. No open-⁠market sales on record. The newest is Susan E. Morano, Director, who bought $100K on Aug 25. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.